The panel members have substantial clinical experience in the diagnosis and treatment of patients with rare metabolic diseases, including patients diagnosed and treated for ARG1-D, which is notably the rarest disease among urea cycle disorders. The gene discussed is ARG1; the disease is metabolic disease.